tiprankstipranks
Advertisement
Advertisement

Afya Posts Higher 2025 Revenue and Profit in Unaudited SEC Filing

Story Highlights
  • Afya reported rising 2025 revenue, profit and assets, signaling stronger financial performance.
  • Improved liquidity and higher equity in 2025 highlight Afya’s expanding scale and resilience for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Afya Posts Higher 2025 Revenue and Profit in Unaudited SEC Filing

Claim 55% Off TipRanks

Afya ( (AFYA) ) has issued an update.

On March 11, 2026, Afya Limited, a foreign private issuer listed in the United States, submitted a Form 6-K to the SEC containing its unaudited consolidated financial statements as of December 31, 2025 and 2024, and for the fiscal years 2023–2025. The filing shows continued expansion, with total assets rising to R$9.36 billion in 2025 from R$8.83 billion in 2024 and revenue climbing to R$3.70 billion from R$3.30 billion, while net income attributable to shareholders increased to R$752.5 million, highlighting stronger profitability and a solid equity base despite higher finance expenses.

Afya’s balance sheet indicates improved liquidity, with cash and cash equivalents up to R$1.13 billion and current liabilities decreasing to R$884.0 million in 2025, contributing to a rise in total equity to R$4.89 billion. The results underscore Afya’s growing scale and operating efficiency in Brazil’s medical education sector and are likely to be closely watched by investors tracking the company’s leverage profile, earnings growth, and ability to sustain expansion in a competitive education market.

The most recent analyst rating on (AFYA) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.

Spark’s Take on AFYA Stock

According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.

Afya’s strong financial performance and positive earnings call are the most significant factors contributing to its score. The company’s robust revenue growth, profitability, and strategic achievements in the earnings call highlight its potential for future success. Technical analysis indicates some bearish momentum, but valuation metrics suggest the stock is reasonably priced.

To see Spark’s full report on AFYA stock, click here.

More about Afya

Afya Limited is a Brazilian education group focused on medical and health sciences training and related educational services. The company operates higher-education institutions and digital platforms serving students and professionals in Brazil’s healthcare sector, positioning itself as a leading player in the country’s medical education market.

Average Trading Volume: 112,730

Technical Sentiment Signal: Sell

Current Market Cap: $1.26B

Find detailed analytics on AFYA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1